Federal Court Dismisses Products Liability Challenge to Social Media Platforms’ Content Moderation Tools -
A recent federal court decision dismissed a products liability challenge to social media platforms’ content...more
PFAS Out, Libel In: Testing the Boundaries of Defamation and Tortious Interference -
A turf manufacturer who recently developed a PFAS-free turf sues for defamation after an environmental organization makes a blanket...more
2/28/2025
/ Appeals ,
Class Action ,
Contamination ,
Defamation ,
Environmental Protection Agency (EPA) ,
Food and Drug Administration (FDA) ,
PFAS ,
Public Health ,
SCOTUS ,
Tort ,
Toxic Chemicals
FDA Issues New Rule for Nonprescription Drugs with Additional Conditions of Use -
The FDA has issued a final rule establishing requirements for the development and marketing of nonprescription drug products with an...more
1/31/2025
/ Climate Change ,
Compliance ,
Environmental Protection Agency (EPA) ,
Final Rules ,
Food and Drug Administration (FDA) ,
Multidistrict Litigation ,
PFAS ,
Pharmaceutical Industry ,
Regulatory Requirements ,
SCOTUS ,
Strict Product Liability ,
Tort ,
Toxic Chemicals
PFAS in the Spotlight: EPA and FDA Zero in on Seafood and Water The 2024 PFAS Strategic Roadmap highlights EPA’s desire to implement further regulation and oversight to study and reduce exposure to PFAS. Seafood and...more
EPA to Expand PFAS Reporting and Delay Separate PFAS Reporting Rule -
EPA’s recent regulations highlight the complexities in its expanding oversight of hundreds of PFAS compounds....more
New decision from the District Court for the Eastern District of New York finds that the FDA has exclusive authority to determine whether OTC drugs are effective.
Court found that manufacturers of OTC drugs do not have an...more